Novartis Pharmaceuticals Corporation
RSS
Novartis sweeps away 'Zelnorm' from the market shelves
Mar 31 2007, Anupam Agnihotri

After the request from Food and Drug Administration (FDA), drug giant Novartis Pharmaceuticals Corporation of East Hanover, New Jersey has withdrew Zelnorm from the market.

FDA’s this decision came after Novartis, the Swiss pharmaceutical company,...

Related Stories
Most Recent Most Popular Most Commented
(0)
Novartis posts 14 percent drop in 1Q profit
AP, Geneva
Pharmaceuticals maker Novartis AG reported Thursday a 14 percent decline in first-quarter net profit in part due to shifts in currency values as well as the cost of...
EU, Switzerland, Earns, Novartis
made popular Apr 23 2009
(0)
Cherry-flavored malaria drug launched for kids
AP, Dakar
Swiss pharmaceutical company Novartis is launching a new cherry-flavored malaria drug that it says children will be less likely to spit out.
AF, Senegal, Malaria, Drug
made popular Feb 20 2009
(0)
Novartis posts 62 pct rise in 4Q net profit
AP, Basel
Drugmaker Novartis AG reported a 62 percent rise in fourth quarter net profit Wednesday, helped by steady sales growth and the absence of the restructuring charges that...
EU, Switzerland, Earns, Novartis
made popular Jan 28 2009
(0)
Novartis gets approval to market 4 drugs in Japan
AP, Basel
Novartis AG said Wednesday it has received approval in Japan to market four drugs to treat asthma, cancer, hypertension and blindness.
EU, Switzerland, Novartis, Business
made popular Jan 21 2009
(0)
Novartis to build $486M plant in North Carolina
AP, Basel
Swiss pharmaceutical giant Novartis AG said Thursday it has secured a $486 million contract to build a new flu vaccine plant in the United States.
EU, Switzerland, Novartis, US
made popular Jan 15 2009
(0)
Novartis acquires license to CMV vaccine candidate
AP, Basel
Swiss pharmaceutical giant Novartis AG said Monday it has licensed a potential vaccine for a type of herpes virus from U.S.-based company AlphaVax Inc.
EU, Switzerland, Novartis, CMV
made popular Dec 29 2008
(0)
FDA: Novartis malaria pill shows superior results
AP, Washington
Federal regulators said Monday a combination drug from Novartis to treat malaria works better than older drugs already on the market.
Novartis, Malaria, Drug, Business
made popular Dec 1 2008
(0)
Novartis to buy Nektar's pulmonary unit for $115M
AP, Basel
Pharmaceutical giant Novartis AG said Tuesday it will buy the pulmonary drug unit of California-based Nektar Therapeutics for $115 million.
EU, Switzerland, Novartis, Nektar
made popular Oct 21 2008
(0)
Novartis posts 32-percent rise in 3Q net profit
AP, Basel
Drug maker Novartis AG on Monday reported a 32-percent rise in net profit for the third quarter due to strong sales and the positive impact from a weak U.S. dollar.
EU, Switzerland, Earns, Novartis
made popular Oct 20 2008
(0)
Novartis posts 17 percent rise in 2Q net income
AP, Basel
Drug maker Novartis AG on Thursday reported a 17 percent increase in net income for the second quarter, thanks to recent acquisitions and strong sales.Net income rose...
Switzerland, Novartis, Business, Drug
made popular Jul 17 2008
(0)
Novartis closer to $38B Alcon takeover
AP, Basel
Novartis AG said Tuesday it has completed the first stage of its $38 billion takeover of U.S. eye-care company Alcon Inc.The Swiss pharmaceuticals company paid current...
Switzerland, Novartis, Alcon, Business
made popular Jul 8 2008
(0)
FDA stresses birth defect risks with Roche drug
AP, Washington
Health regulators reiterated their warning Friday that organ transplant drugs from Roche and Novartis can cause miscarriages and birth defects when used by pregnant...
FDA, Warning, Roche, Drug
made popular May 16 2008
(0)
Vaccines pump up Novartis 1Q profits; US sales down
AP, Basel
Pharmaceuticals maker Novartis AG reported a 7 percent rise in first-quarter profits Monday on the back of a declining dollar and solid performance in its vaccines and...
Earns, Switzerland, Novartis, Business
made popular Apr 21 2008
(0)
FDA Investigates Transplant Drugs' Risks
AP, Washington
Regulators are exploring whether organ transplant drugs made by Roche and Novartis increase the risk of an often-fatal neurological disease.The Food and Drug...
Roche, FDA, Investigation, Technology
made popular Apr 10 2008
(0)
Novartis Spending $39 Billion for Alcon
AP, Geneva
Switzerland’s Novartis AG said Monday it will spend about $39 billion in a two-step bid for a majority stake in U.S. eye-care company Alcon.The deal for Alcon...
Switzerland, Novartis, Alcon, Business
made popular Apr 7 2008
(0)
Novartis Spending $38 Billion for Alcon
AP, Basel
Switzerland’s Novartis AG said Monday it will spend about $38 billion in a two-step bid for a majority stake in U.S. eye-care company Alcon.The pharmaceutical...
Switzerland, Novartis, Alcon, Business
made popular Apr 7 2008
(0)
Novartis to Cut 2,500 Jobs by 2010
AP, Basel
Novartis AG will cut 2,500 jobs worldwide by 2010 in an attempt to save $1.6 billion, the drug maker said Thursday.The company said it would take a restructuring charge...
Europe, NorthAmerica, Switzerland, United States
made popular Dec 13 2007
(0)
Correction: FDA Approves Leukemia Drug
AP, Washington
In the headline of an Oct. 29 story about the FDA’s approval of a new leukemia drug, The Associated Press misspelled the name of the company and the disease. The...
Novartis, Leukemia, CORRECTIVE, Scitech
made popular Oct 30 2007
(0)
FDA Approves Drug to Treat Leukemia
AP, Washington
A second-line drug to treat a life-threatening form of leukemia has won federal approval, the Food and Drug Administration said Monday.Tasigna, known generically as...
Europe, NorthAmerica, Switzerland, United States
made popular Oct 29 2007
(0)
Novartis: EU Approves Alzheimer's Patch
AP, Basel
The drugmaker Novartis AG said Monday that the European Commission had approved its Exelon skin patch to treat Alzheimer’s disease.The patch, which was approved...
Europe, NorthAmerica, Switzerland, United States
made popular Sep 24 2007
All Stories
Most Recent Most Popular Most Commented
Related Tags
FDA Food and Drug Administration Health & Fitness Novartis Zelnorm
12Next
FAQ / Help
Move to top